詳細検索

詳細検索

×

キーワード検索の使い方

×
A
B
C
D
E
F
G
H
I
J
L
M
O
P
Q
R
S
T
U
V
W
X
日

お問い合わせ

バイオ医薬品受託製造市場レポート：2026-2036年

バイオ医薬品受託製造市場レポート：2026-2036年


Biopharmaceuticals Contract Manufacturing Market Report 2026-2036

説明 Visiongainは、新たなレポート『バイオ医薬品受託製造市場レポート 2026-2036』を発表しました。 世界のバイオ医薬品受託製造市場は、2026年に208億9,000万米ドルの規模となり、予測期間中は年平... もっと見る

　

　

出版社
Visiongain
ヴィジョンゲイン社
出版年月
2026年10月11日
電子版価格
GBP5,150
部署ライセンス
ライセンス・価格情報／注文方法はこちら
納期
2営業日程度
ページ数
425
言語
英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページはAI翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

説明

Visiongainは、新たなレポート『バイオ医薬品受託製造市場レポート 2026-2036』を発表しました。 世界のバイオ医薬品受託製造市場は、2026年に208億9,000万米ドルの規模となり、予測期間中は年平均成長率（CAGR）12.7％で拡大し、2036年には691億1,000万米ドルに達すると予測されています。

本レポートでは、市場規模、成長要因、競合状況、および調達元、サービス、製品、企業規模、事業規模、治療領域の各セグメントにわたる収益予測など、市場に関する包括的な分析を提供しています。

契約サービスがもたらすコスト削減と時間短縮のメリット

アウトソーシングに伴うコスト削減と業務効率化が、バイオ医薬品の受託製造市場の成長を牽引し続けています。 CDMOと提携することで、バイオ医薬品企業は、施設建設、専用設備、製造要員への多額の投資を回避しつつ、確立されたインフラや技術的専門知識を活用することができる。このアプローチは、臨床開発を通じて製品を前進させようとする新興のバイオテクノロジー企業や、社内リソースをイノベーションやポートフォリオの拡大に集中させたいと考える老舗製薬企業にとって、特に有益である。

インフラの共有化により、これらのメリットはさらに高まります。CDMOは、モジュール式生産技術、シングルユースシステム、専用の充填・仕上げ設備を備えた柔軟性の高い製造施設を運営しており、これにより複数のプロジェクトを同時に遂行できるだけでなく、施設の利用率を向上させ、運営コストを削減することが可能です。こうした能力により、スポンサーは、専用の生産資産に多額の資本を投じる必要なく、拡張性の高い製造サービスを利用することができます。

コスト削減に加え、アウトソーシングは、確立されたプラットフォームプロセス、統合された品質システム、およびエンドツーエンドのサービス提供を通じて、製造スケジュールを短縮することができます。これらの機能により、技術移転が促進され、スケールアップ作業が簡素化され、臨床開発から商業生産への移行がより効率的に行えるようになります。 2025年2月、Recipharm社は、再バリデーション要件を最小限に抑えつつ、臨床用バッチの生産を迅速化するように設計されたモジュール式のグレードAアイソレーターラインを発表し、製造の俊敏性と業務の効率化に対する重視が高まっていることを浮き彫りにしました。

レポートの範囲とデータの対象範囲

  • 世界のバイオ医薬品受託製造市場の分析
  • 2036年までの売上高予測と年間成長率の見通し
  • ソース、サービス、製品、企業規模、事業規模、および治療領域にわたるセグメントレベルのモデリング
  • 5つの地域および22の主要国内市場にわたる地域別・国内市場予測
  • 主要22社に関する競合情報

技術、競合状況、貿易動向、サプライチェーンの動向などを網羅した、定量的な予測と定性的な戦略分析の両方を含んでいます。

425ページにわたる本報告書には、151の表と204の図表・グラフが掲載されています。

セグメンテーションの枠組み

ソース別

  • 哺乳類
  • 非哺乳類

サービス別

  • プロセス開発
  • 下流
  • 上流
  • 充填・仕上げ工程
  • 分析および品質管理（QC）試験
  • パッケージ

製品別

  • 生物学的製剤
  • モノクローナル抗体（mAbs）
  • 組換えタンパク質
  • ワクチン
  • その他
  • バイオシミラー

企業規模別

  • 小
  • 中
  • 大

事業規模別

  • 前臨床
  • 臨床
  • コマーシャル

治療領域別

  • 腫瘍学
  • 自己免疫疾患
  • 心血管疾患
  • 代謝性疾患
  • 感染症
  • 神経学
  • その他

対象地域

北米

  • アメリカ合衆国
  • カナダ

欧州

  • ドイツ
  • イギリス
  • フランス
  • イタリア
  • スペイン
  • ロシア
  • オランダ
  • スイス
  • その他の欧州地域

アジア太平洋地域

  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • 東南アジア
  • その他のアジア太平洋地域

ラテンアメリカ

  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
  • その他のラテンアメリカ

中東・アフリカ

  • GCC
  • 南アフリカ
  • その他の中東・アフリカ地域

Biopharmaceuticals Contract Manufacturing Market Report 2026-2036

企業情報に関する報道

本レポートには、以下を含む22社の主要企業の詳細なプロフィールが掲載されています：

  • AbbVie Inc.
  • AGC Biologics
  • Avantor, Inc.
  • Boehringer Ingelheim GmbH
  • Bynex Co., Ltd.
  • Cambrex Corporation
  • Catalent, Inc. (A Novo Holdings Company)
  • Curia Global, Inc.
  • Cytiva
  • FUJIFILM Diosynth Biotechnologies
  • JRS Pharma
  • Jubilant Pharma Limited
  • KBI Biopharma
  • Lonza
  • Pfizer CentreOne
  • ProBioGen AG
  • Rentschler Biopharma SE
  • Samsung Biologics
  • Sandoz Group AG
  • Thermo Fisher Scientific Inc.
  • TOYOBO CO., LTD.
  • WuXi Biologics

各プロフィールには以下の内容が含まれています：

  • 事業概要
  • 財務および市場における位置づけ
  • 技術ロードマップとプログラムの成果
  • 戦略的展望

主な疑問への回答

  • バイオ医薬品の受託製造市場はどのように変化しているのでしょうか？
  • バイオ医薬品の受託製造市場を牽引し、抑制している要因は何でしょうか？
  • 予測期間において、バイオ医薬品の受託製造の各サブマーケットセグメントはどのように成長し、2036年にはこれらのサブマーケットが売上高のどの程度の割合を占めることになるのでしょうか？
  • 2026年から2036年にかけて、バイオ医薬品の受託製造の各サブマーケットにおける市場シェアはどのように推移するでしょうか？
  • 主要なバイオ医薬品受託製造市場は、概してマクロ経済の動向に追随するのでしょうか、それとも個々の国の市場が他を凌ぐパフォーマンスを示すのでしょうか？
  • 主要企業はどの企業であり、予測期間におけるその見通しはどのようなものか？
  • 2026年から2036年にかけて、この業界はどのように変化していくのでしょうか？
  • 新製品や新サービスラインにとって、最適な投資選択肢は何でしょうか？


お問い合わせ

お問合せ種類／内容 *

補足が有ればご記入ください
貴社名*
ご担当者名 * 姓 名
メールアドレス *

ページTOPに戻る


目次

1 レポートの概要
1.1 本調査の目的
1.2 バイオ医薬品の受託製造市場の概要
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問：
1.6 本レポートの対象読者
1.7 調査方法
1.7.1 市場の定義
1.7.2 市場評価および予測の方法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 二次調査
1.8 よくある質問（FAQ）
1.9 関連するVisiongainレポート
1.10 Visiongainについて

2 概要

3 市場の概要
3.1 主な調査結果
3.2 市場の動向
3.3 影響分析
3.3.1 市場の推進要因
3.3.1.1 生産能力拡大に向けたCMOによる投資の増加
3.3.1.2 受託サービスがもたらすコスト削減・時間短縮のメリット
3.3.1.3 市場成長の原動力としてのアウトソーシング
3.3.1.4 希少疾病用医薬品への投資拡大
3.3.1.5 製造技術の進歩
3.3.1.6 生物製剤およびバイオシミラーへの需要の高まり
3.3.2 市場の抑制要因
3.3.2.1 市場成長を阻害する価格圧力
3.3.2.2 規制環境
3.3.2.3 市場成長の課題となる見込みの過剰生産能力
3.3.2.4 熟練したバイオプロセスエンジニアの世界的な不足
3.3.3 市場の機会
3.3.3.1 充填・仕上げ（Fill and Finish）CMOの拡大
3.3.3.2 シングルユース型バイオプロセス機器およびソリューションの台頭
3.3.3.3 新興経済国が有望な成長機会を提供
3.3.3.4 AIを活用した予測型バイオプロセス制御による収率向上
3.1 米国の関税：バイオ医薬品受託製造市場への影響は？
3.1.1 概要
3.1.2 V字型回復シナリオ
3.1.3 なぜV字型回復なのか？
3.1.3.1 関税による影響
3.1.3.2 市場の動向と需要の回復
3.1.3.3 政策および資金支援
3.1.3.4 回復までの期間
3.1.4 U字型回復シナリオ
3.1.4.1 なぜU字型回復なのか？
3.1.4.2 関税の影響
3.1.4.3 市場の動向と需要の回復
3.1.4.4 政策および資金面での支援
3.1.4.5 回復までの期間
3.1.5 L字型回復シナリオ
3.1.5.1 なぜL字型回復なのか？
3.1.5.2 関税の影響
3.1.5.3 市場の動向と需要の回復
3.1.5.4 政策および資金面での支援
3.1.5.5 回復までの期間
3.1.6 顧客は、短期（2026～2031年）および長期（2026～2036年）の計画において、どのような戦略的考慮事項を織り込むべきか？
3.1.7 米中貿易戦争がバイオ医薬品の受託製造市場に与える影響
3.1.8 最も影響を受ける国々は、これらの政策変更によってどのようなプラスおよびマイナスの影響を受ける可能性があるか？
3.2 SWOT分析
3.2.1 強み
3.2.2 弱み
3.2.3 機会
3.2.4 脅威
3.3 ポーターの5つの力分析
3.3.1 買い手の交渉力
3.3.2 供給者の交渉力
3.3.3 競合他社間の競争
3.3.4 代替品の脅威
3.3.5 新規参入者の脅威
3.4 PEST分析
3.4.1 バイオ医薬品受託製造市場に影響を与える政治的要因
3.4.2 バイオ医薬品受託製造市場に影響を与える経済的要因
3.4.3 バイオ医薬品受託製造市場に影響を与える社会的要因
3.4.4 バイオ医薬品受託製造市場に影響を与える技術的要因

4 バイオ医薬品の受託製造市場分析：ソース別
4.1 主な調査結果
4.2 原料セグメント：市場魅力度指数
4.3 原料別バイオ医薬品受託製造市場の規模推計および予測
4.4 哺乳類
4.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
4.4.2 地域別市場シェア（2026年および2036年）（％）
4.5 非哺乳類
4.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
4.5.2 地域別市場シェア（2026年および2036年）（％）

5 バイオ医薬品受託製造市場分析：サービス別
5.1 主な調査結果
5.2 サービスセグメント：市場魅力度指数
5.3 サービス別バイオ医薬品受託製造市場の規模推計および予測
5.4 プロセス開発
5.4.1 アップストリームプロセス開発
5.4.2 ダウンストリームプロセス開発
5.4.3 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
5.4.4 地域別市場シェア（2026年および2036年）（％）
5.5 充填・仕上げ工程
5.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
5.5.2 地域別市場シェア（2026年および2036年）（％）
5.6 分析および品質管理（QC）調査
5.6.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
5.6.2 地域別市場シェア、2026年および2036年（％）
5.7 包装
5.7.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
5.7.2 地域別市場シェア、2026年および2036年（％）

6 バイオ医薬品の受託製造市場分析：製品別
6.1 主な調査結果
6.2 製品セグメント：市場魅力度指数
6.3 バイオ医薬品の受託製造市場規模の推計および製品別予測
6.4 バイオ医薬品
6.4.1 地域別市場予測：2026年～2036年（百万米ドル、年平均成長率％）
6.4.2 地域別市場シェア：2026年および2036年（％）
6.5 バイオシミラー
6.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
6.5.2 地域別市場シェア（2026年および2036年）（％）

7 バイオ医薬品受託製造市場分析：企業規模別
7.1 主な調査結果
7.2 企業規模別セグメント：市場魅力度指数
7.3 企業規模別のバイオ医薬品受託製造市場の規模推計および予測
7.4 小規模企業
7.4.1 地域別市場予測、2026年～2036年、百万米ドル、年平均成長率（AGR）％）
7.4.2 地域別市場シェア（2026年および2036年、％）
7.5 中規模
7.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
7.5.2 地域別市場シェア、2026年および2036年（％）
7.6 大型
7.6.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
7.6.2 地域別市場シェア、2026年および2036年（％）

8 バイオ医薬品の受託製造市場分析：事業規模別
8.1 主な調査結果
8.2 事業規模別セグメント：市場魅力度指数
8.3 事業規模別のバイオ医薬品受託製造市場の規模推計および予測
8.4 前臨床
8.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
8.4.2 地域別市場シェア（2026年および2036年）（％）
8.5 臨床段階
8.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率％）
8.5.2 地域別市場シェア、2026年および2036年（％）
8.6 商業
8.6.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率％）
8.6.2 地域別市場シェア、2026年および2036年（％）

9 バイオ医薬品受託製造市場の分析：治療領域別
9.1 主な調査結果
9.2 治療領域別セグメント：市場魅力度指数
9.3 治療領域別のバイオ医薬品受託製造市場の規模推計および予測
9.4 オンコロジー
9.4.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
9.4.2 地域別市場シェア（2026年および2036年）（％）
9.5 自己免疫疾患
9.5.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率％）
9.5.2 地域別市場シェア、2026年および2036年（％）
9.6 心血管疾患
9.6.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
9.6.2 地域別市場シェア、2026年および2036年（％）
9.7 代謝性疾患
9.7.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
9.7.2 地域別市場シェア、2026年および2036年（％）
9.8 感染症
9.8.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
9.8.2 地域別市場シェア、2026年および2036年（％）
9.9 神経学
9.9.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率（AGR）％）
9.9.2 地域別市場シェア、2026年および2036年（％）
9.10 その他
9.10.1 地域別市場予測、2026年～2036年（百万米ドル、年平均成長率％）
9.10.2 地域別市場シェア、2026年および2036年（％）

10 バイオ医薬品受託製造市場分析：地域別
10.1 主な調査結果
10.2 地域別市場規模の推計と予測

11 北米のバイオ医薬品受託製造市場分析
11.1 主な調査結果
11.2 北米バイオ医薬品受託製造市場の魅力度指数
11.3 北米バイオ医薬品受託製造市場：国別、2026年、2031年、2036年（百万米ドル）
11.4 北米バイオ医薬品受託製造市場の規模推計および予測：国別
11.5 北米バイオ医薬品受託製造市場の規模推計および予測：ソース別
11.6 北米バイオ医薬品受託製造市場の規模推計および予測：サービス別
11.7 北米バイオ医薬品受託製造市場の規模推計および予測：製品別
11.8 北米バイオ医薬品受託製造市場の規模推計および予測：企業規模別
11.9 北米バイオ医薬品受託製造市場の規模推計および予測：事業規模別
11.10 北米バイオ医薬品受託製造市場の規模推計および予測：治療領域別
11.11 米国バイオ医薬品受託製造市場の分析
11.12 カナダバイオ医薬品受託製造市場の分析

12 欧州のバイオ医薬品受託製造市場分析
12.1 主な調査結果
12.2 欧州バイオ医薬品受託製造市場の魅力度指数
12.3 欧州バイオ医薬品受託製造市場：国別、2026年、2031年、2036年（百万米ドル）
12.4 欧州バイオ医薬品受託製造市場の規模推計および予測：国別
12.5 欧州バイオ医薬品受託製造市場の規模推計および予測：ソース別
12.6 欧州バイオ医薬品受託製造市場の規模推計および予測：サービス別
12.7 欧州バイオ医薬品受託製造市場の規模推計および予測：製品別
12.8 欧州バイオ医薬品受託製造市場の規模推計および予測：企業規模別
12.9 欧州バイオ医薬品受託製造市場の規模推計および予測：事業規模別
12.10 欧州バイオ医薬品受託製造市場の規模推計および予測：治療領域別
12.11 ドイツのバイオ医薬品受託製造市場分析
12.12 英国のバイオ医薬品受託製造市場の分析
12.13 フランスのバイオ医薬品受託製造市場の分析
12.14 イタリアのバイオ医薬品受託製造市場の分析
12.15 スペインのバイオ医薬品受託製造市場の分析
12.16 ロシアのバイオ医薬品受託製造市場分析
12.17 オランダのバイオ医薬品受託製造市場分析
12.18 スイスのバイオ医薬品受託製造市場分析
12.19 その他の欧州諸国のバイオ医薬品受託製造市場分析

13 アジア太平洋地域のバイオ医薬品受託製造市場の分析
13.1 主な調査結果
13.2 アジア太平洋地域のバイオ医薬品受託製造市場の魅力度指数
13.3 アジア太平洋地域のバイオ医薬品受託製造市場：国別、2026年、2031年、2036年（百万米ドル）
13.4 アジア太平洋地域のバイオ医薬品受託製造市場規模の推計および予測：国別
13.5 アジア太平洋地域のバイオ医薬品受託製造市場規模の推計および予測：ソース別
13.6 アジア太平洋地域のバイオ医薬品受託製造市場規模の推計および予測：サービス別
13.7 アジア太平洋地域のバイオ医薬品受託製造市場規模の推計および予測：製品別
13.8 アジア太平洋地域のバイオ医薬品受託製造市場規模の推計および予測：企業規模別
13.9 アジア太平洋地域のバイオ医薬品受託製造市場規模の推計および予測：事業規模別
13.10 アジア太平洋地域のバイオ医薬品受託製造市場規模の推計および予測：治療領域別
13.11 日本のバイオ医薬品受託製造市場の分析
13.12 中国のバイオ医薬品受託製造市場の分析
13.13 インドのバイオ医薬品受託製造市場の分析
13.14 オーストラリアのバイオ医薬品受託製造市場の分析
13.15 韓国のバイオ医薬品受託製造市場の分析
13.16 東南アジアのバイオ医薬品受託製造市場の分析
13.17 アジア太平洋地域のその他の地域のバイオ医薬品受託製造市場の分析

14 ラテンアメリカのバイオ医薬品受託製造市場分析
14.1 主な調査結果
14.2 ラテンアメリカのバイオ医薬品受託製造市場の魅力度指数
14.3 ラテンアメリカのバイオ医薬品受託製造市場：国別、2026年、2031年、2036年（百万米ドル）
14.4 ラテンアメリカのバイオ医薬品受託製造市場の規模推計および予測：国別
14.5 ラテンアメリカのバイオ医薬品受託製造市場の規模推計および予測：ソース別
14.6 ラテンアメリカのバイオ医薬品受託製造市場の規模推計および予測：サービス別
14.7 ラテンアメリカのバイオ医薬品受託製造市場の規模推計および予測：製品別
14.8 ラテンアメリカのバイオ医薬品受託製造市場の規模推計および予測：企業規模別
14.9 ラテンアメリカのバイオ医薬品受託製造市場の規模推計および予測：事業規模別
14.10 ラテンアメリカのバイオ医薬品受託製造市場の規模推計および予測：治療領域別
14.11 ブラジルのバイオ医薬品受託製造市場の分析
14.12 メキシコのバイオ医薬品受託製造市場の分析
14.13 アルゼンチンのバイオ医薬品受託製造市場の分析
14.14 コロンビアのバイオ医薬品受託製造市場の分析
14.15 その他のラテンアメリカ諸国のバイオ医薬品受託製造市場の分析

15 MEA バイオ医薬品受託製造市場の分析
15.1 主な調査結果
15.2 MEAバイオ医薬品受託製造市場の魅力度指数
15.3 MEAバイオ医薬品受託製造市場：国別、2026年、2031年、2036年（百万米ドル）
15.4 MEAバイオ医薬品受託製造市場の規模推計および予測：国別）
15.5 MEAバイオ医薬品受託製造市場の規模推計および予測：ソース別
15.6 MEAバイオ医薬品受託製造市場の規模推計および予測：サービス別
15.7 MEAバイオ医薬品受託製造市場の規模推計および予測：製品別
15.8 MEAバイオ医薬品受託製造市場の規模推計および予測：企業規模別
15.9 MEAバイオ医薬品受託製造市場の規模推計および予測：事業規模別
15.10 MEAバイオ医薬品受託製造市場の規模推計および予測：治療領域別
15.11 GCC地域のバイオ医薬品受託製造市場の分析
15.12 南アフリカのバイオ医薬品受託製造市場の分析
15.13 MEA地域のその他の地域のバイオ医薬品受託製造市場の分析

16 主要企業のプロフィール
16.1 AbbVie, Inc.
16.1.1 企業概要
16.1.2 会社概要
16.1.3 財務分析
16.1.3.1 純売上高（2022年～2025年）
16.1.3.2 研究開発費（2022年～2025年）
16.1.3.3 地域別市場シェア（2025年）
16.1.3.4 事業セグメント別市場シェア（2025年）
16.1.4 サービスベンチマーキング
16.2 AGC Biologics
16.2.1 企業概要
16.2.2 会社概要
16.2.3 サービスベンチマーキング
16.2.4 戦略的展望
16.3 Avantor, Inc.
16.3.1 企業概要
16.3.2 会社概要
16.3.3 財務分析
16.3.3.1 純売上高（2022年～2025年）
16.3.3.2 地域別市場シェア（2025年）
16.3.3.3 事業セグメント別市場シェア（2025年）
16.3.4 サービスベンチマーク
16.3.5 戦略的展望
16.4 Binex Co., Ltd.
16.4.1 企業概要
16.4.2 会社概要
16.4.3 サービスベンチマーク
16.5 Boehringer Ingelheim GmbH
16.5.1 企業概要
16.5.2 会社概要
16.5.3 財務分析
16.5.3.1 純売上高（2022年～2025年）
16.5.3.2 研究開発費（2022年～2025年）
16.5.3.3 地域別市場シェア（2025年）
16.5.3.4 事業セグメント別市場シェア（2025年）
16.5.4 サービスベンチマーキング
16.6 富士フイルム・ディオシンthバイオテクノロジーズ
16.6.1 企業概要
16.6.2 会社概要
16.6.3 サービスベンチマーキング
16.6.4 戦略的展望
16.7 ロンザ
16.7.1 企業概要
16.7.2 会社概要
16.7.3 財務分析
16.7.3.1 純売上高（2022年～2025年）
16.7.3.2 研究開発費（2022年～2025年）
16.7.3.3 地域別市場シェア（2025年）
16.7.3.4 事業セグメント別市場シェア（2025年）
16.7.4 サービスベンチマーキング
16.7.5 戦略的展望
16.8 プロバイオジェン
16.8.1 企業概要
16.8.2 会社概要
16.8.3 サービスベンチマーキング
16.8.4 戦略的展望
16.9 Rentschler Biopharma SE
16.9.1 企業概要
16.9.2 企業概要
16.9.3 サービスベンチマーク
16.9.4 戦略的展望
16.10 サムスン・バイオロジクス
16.10.1 企業概要
16.10.2 企業概要
16.10.3 サービス・ベンチマーキング
16.10.4 戦略的展望
16.11 サンドーズ
16.11.1 企業概要
16.11.2 会社概要
16.11.3 財務分析
16.11.3.1 純売上高（2022年～2025年）
16.11.3.2 研究開発費（2022年～2025年）
16.11.3.3 地域別市場シェア（2025年）
16.11.3.4 事業セグメント別市場シェア（2025年）
16.11.4 サービスベンチマーク
16.11.5 戦略的展望
16.12 東洋紡株式会社
16.12.1 企業概要
16.12.2 会社概要
16.12.3 サービスベンチマーキング
16.13 ウーシー・バイオロジクス
16.13.1 企業概要
16.13.2 会社概要
16.13.3 財務分析
16.13.3.1 純売上高（2022年～2025年）
16.13.3.2 地域別市場シェア（2025年）
16.13.3.3 事業セグメント別市場シェア（2025年）
16.13.4 サービスベンチマーク
16.13.5 戦略的展望
16.14 JRS PHARMA
16.14.1 企業概要
16.14.2 会社概要
16.14.3 サービスベンチマーク
16.15 サーモフィッシャーサイエンティフィック
16.15.1 企業概要
16.15.2 会社概要
16.15.3 財務分析
16.15.3.1 純売上高（2022年～2025年）
16.15.3.2 研究開発費（R&D）、2022年～2025年
16.15.3.3 地域別市場シェア、2025年
16.15.3.4 事業セグメント別市場シェア、2025年
16.15.4 サービスベンチマーキング
16.16 キャンブレックス・コーポレーション
16.16.1 企業概要
16.16.2 会社概要
16.16.3 サービスベンチマーキング
16.16.4 戦略的展望
16.17 キュリア・グローバル社
16.17.1 企業概要
16.17.2 会社概要
16.17.3 サービスベンチマーキング
16.17.4 戦略的展望
16.18 ファイザー・センターワン
16.18.1 企業概要
16.18.2 会社概要
16.18.3 財務分析
16.18.3.1 純売上高（2022年～2025年）
16.18.3.2 研究開発費（R&D）、2022年～2025年
16.18.3.3 地域別市場シェア、2025年
16.18.3.4 事業セグメント別市場シェア、2025年
16.18.4 サービスのベンチマーク
16.19 ジュビラント・ファーマ・リミテッド
16.19.1 企業概要
16.19.2 会社概要
16.19.3 サービスのベンチマーク
16.20 カタレント社 （Novo Holdings）
16.20.1 企業概要
16.20.2 会社概要
16.20.3 財務分析
16.20.3.1 純売上高（2022年～2025年）
16.20.4 サービスベンチマーク
16.20.5 戦略的展望
16.21 KBI Biopharma
16.21.1 企業概要
16.21.2 会社概要
16.21.3 サービスベンチマーク
16.21.4 戦略的展望
16.22 サイティバ
16.22.1 企業概要
16.22.2 会社概要
16.22.3 サービスベンチマーキング
16.22.4 戦略的展望

17 結論と提言
17.1 Visiongainによる総括
17.2 市場関係者への提言
その他の注目すべき企業のリスト
本レポートで言及された団体のリスト
関連するVisiongainレポート

 

ページTOPに戻る



図表リスト

List of Tables
Table 1 Biopharmaceuticals Contract Manufacturing Market Snapshot, 2026 & 2036 (US$ million, CAGR %)
Table 2 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): “V” Shaped Recovery
Table 3 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): “U” Shaped Recovery
Table 4 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): “L” Shaped Recovery
Table 5 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 6 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 7 Non-mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 8 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 9 Process Development Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 10 Fill & Finish Operations Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 11 Analytical & QC Studies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 12 Packaging Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 13 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 14 Biologics Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 15 Biosimilars Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 16 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 17 Small Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 18 Mid-sized Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 19 Large Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 20 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 21 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 22 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 23 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 24 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 25 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 26 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 27 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 28 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 29 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 30 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 31 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 32 U.S. Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 33 Canada Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 34 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 35 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 36 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 37 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 38 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 39 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 40 Germany Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 41 UK Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 42 France Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 43 Italy Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 44 Spain Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 45 Russia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 46 Netherlands Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 47 Switzerland Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 48 Rest of Europe Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 49 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 50 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 51 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 52 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 53 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 54 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 55 Japan Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 56 China Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 57 India Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 58 Australia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 59 South Korea Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 60 South-East Asia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 61 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 62 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 63 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 64 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 65 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 66 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 67 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 68 Brazil Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 69 Mexico Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 70 Argentina Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 71 Colombia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 72 Rest of Latin America Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 73 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 74 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 75 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 76 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 77 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 78 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 79 GCC Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 80 South Africa Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 81 Rest of MEA Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 82 AbbVie, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 AbbVie, Inc.: Service Benchmarking
Table 84 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 AGC Biologics: Service Benchmarking
Table 86 AGC Biologics: Strategic Outlook
Table 87 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Avantor, Inc.: Service Benchmarking
Table 89 Avantor, Inc.: Strategic Outlook
Table 90 Binex Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Binex Co., Ltd.: Service Benchmarking
Table 92 Boehringer Ingelheim GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Boehringer Ingelheim GmbH: Service Benchmarking
Table 94 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
Table 96 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
Table 97 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Lonza: Service Benchmarking
Table 99 Lonza: Strategic Outlook
Table 100 ProBioGen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 ProBioGen: Service Benchmarking
Table 102 ProBioGen: Strategic Outlook
Table 103 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Rentschler Biopharma SE: Service Benchmarking
Table 105 Rentschler Biopharma SE: Strategic Outlook
Table 106 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Samsung Biologics: Service Benchmarking
Table 108 Samsung Biologics: Strategic Outlook
Table 109 Sandoz: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Sandoz: Service Benchmarking
Table 111 Sandoz: Strategic Outlook
Table 112 TOYOBO CO., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 TOYOBO CO., LTD.: Service Benchmarking
Table 114 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 WuXi Biologics: Service Benchmarking
Table 116 WuXi Biologics: Strategic Outlook
Table 117 JRS PHARMA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 JRS PHARMA: Service Benchmarking
Table 119 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Thermo Fisher Scientific: Service Benchmarking
Table 121 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Cambrex Corporation: Service Benchmarking
Table 123 Cambrex Corporation: Strategic Outlook
Table 124 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Curia Global, Inc.: Service Benchmarking
Table 126 Curia Global, Inc.: Strategic Outlook
Table 127 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Pfizer CentreOne: Service Benchmarking
Table 129 Jubilant Pharma Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Jubilant Pharma Limited: Service Benchmarking
Table 131 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Catalent, Inc: Service Benchmarking
Table 133 Catalent, Inc: Strategic Outlook
Table 134 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 KBI Biopharma: Service Benchmarking
Table 136 KBI Biopharma: Strategic Outlook
Table 137 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Cytiva: Service Benchmarking
Table 139 Cytiva: Strategic Outlook

List of Figures
Figure 1 Biopharmaceuticals Contract Manufacturing Market Segmentation
Figure 2 Biopharmaceuticals Contract Manufacturing Market by Source: Market Attractiveness Index
Figure 3 Biopharmaceuticals Contract Manufacturing Market by Service: Market Attractiveness Index
Figure 4 Biopharmaceuticals Contract Manufacturing Market by Product: Market Attractiveness Index
Figure 5 Biopharmaceuticals Contract Manufacturing Market by Company Size: Market Attractiveness Index
Figure 6 Biopharmaceuticals Contract Manufacturing Market by Scale of Operations: Market Attractiveness Index
Figure 7 Biopharmaceuticals Contract Manufacturing Market by Therapeutic Area: Market Attractiveness Index
Figure 8 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Region
Figure 9 Biopharmaceuticals Contract Manufacturing Market: Market Dynamics
Figure 10 Biopharmaceuticals Contract Manufacturing Market: Impact Analysis
Figure 11 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 12 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 13 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 14 Short Term & Long Term Planning
Figure 15 Impact of U.S. and China Trade War
Figure 1 Most Impacted Countries
Figure 2 SWOT Analysis
Figure 3 Porter’s Five Forces Analysis
Figure 4 PEST Analysis
Figure 5 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
Figure 6 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 7 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026, 2031 & 2036 (%)
Figure 8 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 9 Mammalian Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 10 Non-mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 11 Non-mammalian Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 12 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
Figure 13 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 14 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026, 2031 & 2036 (%)
Figure 15 Process Development Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 16 Process Development Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 17 Fill & Finish Operations Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 18 Fill & Finish Operations Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 19 Analytical & QC Studies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 20 Analytical & QC Studies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 21 Packaging Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 22 Packaging Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 23 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Product
Figure 24 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 25 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026, 2031 & 2036 (%)
Figure 26 Biologics Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 27 Biologics Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 28 Biosimilars Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 29 Biosimilars Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 30 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Company Size
Figure 31 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 32 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026, 2031 & 2036 (%)
Figure 33 Small Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 34 Small Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Mid-sized Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 36 Mid-sized Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Large Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 38 Large Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 39 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Scale of Operations
Figure 40 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 41 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026, 2031 & 2036 (%)
Figure 42 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 43 Preclinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 44 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 45 Clinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 46 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 47 Commercial Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Therapeutic Area
Figure 49 Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 50 Biopharmaceuticals Contract Manufacturing Market Share Forecast Therapeutic Area, 2026, 2031 & 2036 (%)
Figure 51 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 52 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 53 Autoimmune Diseses Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 54 Autoimmune Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 55 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 56 Cardiovascular Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 57 Metabolic Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 58 Metabolic Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 60 Infectious Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Neurology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 62 Neurology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 63 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 64 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 65 Biopharmaceuticals Contract Manufacturing Market Forecast by Region 2026, 2031 & 2036 (Revenue, CAGR%)
Figure 66 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Region 2026, 2031 & 2036 (%)
Figure 67 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Mn)
Figure 68 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 69 North America Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 70 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 71 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 72 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 73 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 74 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 75 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 76 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 77 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 78 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 79 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 80 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 81 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 82 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 83 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 84 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 85 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 86 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 87 Europe Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 88 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 89 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 90 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 91 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 92 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 93 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 94 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 95 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 96 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 97 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 98 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 99 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 100 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 101 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 102 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 103 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 104 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 105 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 106 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 107 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 108 Netherlands Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 109 Switzerland Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 110 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 111 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 112 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 113 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 114 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 115 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 116 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 117 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 118 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 119 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 120 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 121 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 122 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 123 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 124 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 125 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 126 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 127 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 128 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 129 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 130 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 131 South Korea Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 132 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 133 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 134 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 135 Latin America Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 136 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 137 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 138 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 139 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 140 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 141 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 142 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 143 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 144 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 145 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 146 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 147 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 148 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 149 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 150 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 151 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 152 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 153 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 154 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 155 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 156 MEA Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 157 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 158 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 159 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 160 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 161 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 162 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 163 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 164 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 165 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 166 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 167 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 168 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 169 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 170 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 171 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 172 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 173 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 174 AbbVie, Inc.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 175 AbbVie, Inc.: R&D Expenses, 2022-2025 (US$ Million, AGR %)
Figure 176 AbbVie, Inc.: Regional Market Shares, 2025 (%)
Figure 177 AbbVie, Inc.: Business Segment Market Shares, 2025 (%)
Figure 178 Avantor, Inc.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 179 Avantor, Inc.: Regional Market Shares, 2025 (%)
Figure 180 Avantor, Inc.: Business Segment Market Share, 2025 (%)
Figure 181 Boehringer Ingelheim GmbH: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 182 Boehringer Ingelheim GmbH: R&D Expenses, 2022-2025 (US$ Million, AGR %)
Figure 183 Boehringer Ingelheim GmbH: Regional Market Shares, 2025 (%)
Figure 184 Boehringer Ingelheim GmbH.: Business Segment Market Share, 2025 (%)
Figure 185 Lonza: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 186 Lonza: R&D Expenses, 2022-2025 (US$ Million, AGR %)
Figure 187 Lonza: Regional Market Shares, 2025 (%)
Figure 188 Lonza: Business Segment Market Share, 2025 (%)
Figure 189 Sandoz: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 190 Sandoz: R&D Expenses, 2022-2025 (US$ Million, AGR %)
Figure 191 Sandoz: Regional Market Share (%), 2025
Figure 192 Sandoz: Business Segment Market Share, 2025 (%)
Figure 193 WuXi Biologics: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 194 WuXi Biologics: Regional Market Shares, 2025 (%)
Figure 195 WuXi Biologics: Business Segment Market Shares, 2025 (%)
Figure 196 Thermo Fisher Scientific: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 197 Thermo Fisher Scientific: R&D, 2022-2025 (US$ Million, AGR %)
Figure 198 Thermo Fisher Scientific: Regional Market Shares, 2025 (%)
Figure 199 Thermo Fisher Scientific: Business Segment Market Shares, 2025 (%)
Figure 200 Pfizer CentreOne: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 201 Pfizer CentreOne: R&D, 2022-2025 (US$ Million, AGR %)
Figure 202 Pfizer CentreOne: Regional Market Shares, 2025 (%)
Figure 203 Pfizer CentreOne: Business Segment Market Shares, 2025 (%)
Figure 204 Catalent, Inc: Net Revenue, 2022-2025 (US$ Million, AGR %)

 

　

ページTOPに戻る


　

Summary

Description

Visiongain has published a new report, Biopharmaceuticals Contract Manufacturing Market Report 2026-2036. The global biopharmaceuticals contract manufacturing market is valued at US$20.89bn in 2026 and is forecast to reach US$69.11bn by 2036, at a CAGR of 12.7% over the forecast period.

This report provides a comprehensive analysis of the market including market size, growth drivers, competitive positioning, and revenue forecasts across source, service, product, company size, scale of operations, and therapeutic area segments.

Cost and Time Saving Benefits Offered by Contract Services

The cost and operational efficiencies associated with outsourcing continue to drive growth in the biopharmaceutical contract manufacturing market. By partnering with CDMOs, biopharmaceutical companies can avoid substantial investments in facility construction, specialised equipment, and manufacturing personnel, while gaining access to established infrastructure and technical expertise. This approach is particularly beneficial for emerging biotechnology companies seeking to advance products through clinical development and for established pharmaceutical companies aiming to focus internal resources on innovation and portfolio expansion.

Shared infrastructure further enhances these advantages. CDMOs operate flexible manufacturing facilities equipped with modular production technologies, single-use systems, and dedicated fill-finish capabilities, enabling multiple projects to be executed simultaneously while improving facility utilisation and reducing operational overheads. Such capabilities allow sponsors to access scalable manufacturing services without committing significant capital to dedicated production assets.

In addition to lowering costs, outsourcing can accelerate manufacturing timelines through established platform processes, integrated quality systems, and end-to-end service offerings. These capabilities facilitate technology transfer, simplify scale-up activities, and support a more efficient transition from clinical development to commercial production. In February 2025, Recipharm introduced a modular Grade A isolator line designed to support faster clinical batch production with minimal revalidation requirements, highlighting the growing emphasis on manufacturing agility and streamlined operations.

Report Scope and Data Coverage

  • Global biopharmaceuticals contract manufacturing market analysis
  • Revenue forecasts to 2036 with annual growth estimates
  • Segment-level modelling across source, service, product, company size, scale of operations, and therapeutic area
  • Regional and national market forecasts across five regions and 22 leading national markets
  • Competitive intelligence on 22 leading companies

Includes both quantitative forecasting and qualitative strategic analysis covering technology, competition, trade dynamics, and supply chain developments.

Our 425-page report provides 151 tables and 204 charts/graphs.

Segmentation Framework

By Source

  • Mammalian
  • Non-mammalian

By Service

  • Process Development
  • Downstream
  • Upstream
  • Fill & Finish Operations
  • Analytical & QC Studies
  • Packaging

By Product

  • Biologics
  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Others
  • Biosimilars

By Company Size

  • Small
  • Mid-sized
  • Large

By Scale of Operations

  • Preclinical
  • Clinical
  • Commercial

By Therapeutic Area

  • Oncology
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Infectious Diseases
  • Neurology
  • Others

Geographic Coverage

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

Middle East and Africa

  • GCC
  • South Africa
  • Rest of MEA

Biopharmaceuticals Contract Manufacturing Market Report 2026-2036

Company Intelligence Coverage

This report includes detailed profiles of 22 leading companies, including:

  • AbbVie Inc.
  • AGC Biologics
  • Avantor, Inc.
  • Boehringer Ingelheim GmbH
  • Bynex Co., Ltd.
  • Cambrex Corporation
  • Catalent, Inc. (A Novo Holdings Company)
  • Curia Global, Inc.
  • Cytiva
  • FUJIFILM Diosynth Biotechnologies
  • JRS Pharma
  • Jubilant Pharma Limited
  • KBI Biopharma
  • Lonza
  • Pfizer CentreOne
  • ProBioGen AG
  • Rentschler Biopharma SE
  • Samsung Biologics
  • Sandoz Group AG
  • Thermo Fisher Scientific Inc.
  • TOYOBO CO., LTD.
  • WuXi Biologics

Each profile includes:

  • Business overview
  • Financial and market positioning
  • Technology roadmap and programme wins
  • Strategic outlook

Key Questions Answered

  • How is the biopharmaceuticals contract manufacturing market evolving?
  • What is driving and restraining the biopharmaceuticals contract manufacturing market?
  • How will each biopharmaceuticals contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2036?
  • How will the market shares for each biopharmaceuticals contract manufacturing submarket develop from 2026 to 2036?
  • Will leading biopharmaceuticals contract manufacturing markets broadly follow macroeconomic dynamics, or will individual national markets outperform others?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2026 and 2036?
  • What are the best investment options for new product and service lines?


ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biopharmaceuticals Contract Manufacturing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Rise in Investment by CMOs for Capacity Expansion
3.3.1.2 Cost and Time Saving Benefits Offered by Contract Services
3.3.1.3 Outsourcing as a Driver for Market Growth
3.3.1.4 Growing Investments in Orphan Drugs
3.3.1.5 Advancements in Manufacturing Technologies
3.3.1.6 Rising demand for Biologics and Biosimilars
3.3.2 Market Restraining Factors
3.3.2.1 Pricing Pressure to Impede Market Growth
3.3.2.2 Regulatory Scenarios
3.3.2.3 Overcapacity Projected to Challenge Market Growth
3.3.2.4 Global shortage of skilled bioprocess engineers
3.3.3 Market Opportunities
3.3.3.1 Expansion of Fill and Finish CMOs
3.3.3.2 Emergence of Single-Use Bioprocessing Equipment & Solutions
3.3.3.3 Emerging Economies to Offer Lucrative Growth Opportunities
3.3.3.4 AI-driven predictive bioprocess control boosting yield
3.1 U.S. Tariffs: What’s the Impact on Biopharmaceuticals Contract Manufacturing Market?
3.1.1 Overview
3.1.2 V-Shaped Recovery Scenario
3.1.3 Why V-Shaped Recovery?
3.1.3.1 Impact from Tariffs
3.1.3.2 Market Dynamics and Demand Recovery
3.1.3.3 Policy and Funding Support
3.1.3.4 Timeframe for Recovery
3.1.4 U-Shaped Recovery Scenario
3.1.4.1 Why U-Shaped Recovery?
3.1.4.2 Impact from Tariffs
3.1.4.3 Market Dynamics and Demand Recovery
3.1.4.4 Policy and Funding Support
3.1.4.5 Timeframe for Recovery
3.1.5 L Shaped Recovery Scenario
3.1.5.1 Why L-Shaped Recovery?
3.1.5.2 Impact from Tariffs
3.1.5.3 Market Dynamics and Demand Recovery
3.1.5.4 Policy and Funding Support
3.1.5.5 Timeframe for Recovery
3.1.6 What Strategic Considerations Should Clients Factor into Their Near-term (2026–2031) and Long-term (2026–2036) Planning?
3.1.7 Impact of U.S. and China Trade War on Biopharmaceuticals Contract Manufacturing Market
3.1.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.2 SWOT Analysis
3.2.1 Strengths
3.2.2 Weaknesses
3.2.3 Opportunities
3.2.4 Threats
3.3 Porter’s Five Forces Analysis
3.3.1 Bargaining Power of Buyers
3.3.2 Bargaining Power of Suppliers
3.3.3 Competitive Rivalry
3.3.4 Threat of Substitutes
3.3.5 Threat of New Entrants
3.4 PEST Analysis
3.4.1 Political Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.4.2 Economic Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.4.3 Social Factors Impacting Biopharmaceuticals Contract Manufacturing Market
3.4.4 Technological Factors Impacting Biopharmaceuticals Contract Manufacturing Market

4 Biopharmaceuticals Contract Manufacturing Market Analysis by Source
4.1 Key Findings
4.2 Source Segment: Market Attractiveness Index
4.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
4.4 Mammalian
4.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2026 & 2036 (%)
4.5 Non-mammalian
4.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2026 & 2036 (%)

5 Biopharmaceuticals Contract Manufacturing Market Analysis by Service
5.1 Key Findings
5.2 Service Segment: Market Attractiveness Index
5.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
5.4 Process Development
5.4.1 Upstream Process Development
5.4.2 Downstream Process Development
5.4.3 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.4.4 Market Share by Region, 2026 & 2036 (%)
5.5 Fill & Finish Operations
5.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2026 & 2036 (%)
5.6 Analytical & QC Studies
5.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.6.2 Market Share by Region, 2026 & 2036 (%)
5.7 Packaging
5.7.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
5.7.2 Market Share by Region, 2026 & 2036 (%)

6 Biopharmaceuticals Contract Manufacturing Market Analysis by Product
6.1 Key Findings
6.2 Product Segment: Market Attractiveness Index
6.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
6.4 Biologics
6.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2026 & 2036 (%)
6.5 Biosimilars
6.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2026 & 2036 (%)

7 Biopharmaceuticals Contract Manufacturing Market Analysis by Company Size
7.1 Key Findings
7.2 Company Size Segment: Market Attractiveness Index
7.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
7.4 Small
7.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.4.2 Market Share by Region, 2026 & 2036 (%)
7.5 Mid-sized
7.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.5.2 Market Share by Region, 2026 & 2036 (%)
7.6 Large
7.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
7.6.2 Market Share by Region, 2026 & 2036 (%)

8 Biopharmaceuticals Contract Manufacturing Market Analysis by Scale of Operations
8.1 Key Findings
8.2 Scale of Operations Segment: Market Attractiveness Index
8.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
8.4 Preclinical
8.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.4.2 Market Share by Region, 2026 & 2036 (%)
8.5 Clinical
8.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.5.2 Market Share by Region, 2026 & 2036 (%)
8.6 Commercial
8.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
8.6.2 Market Share by Region, 2026 & 2036 (%)

9 Biopharmaceuticals Contract Manufacturing Market Analysis by Therapeutic Area
9.1 Key Findings
9.2 Therapeutic Area Segment: Market Attractiveness Index
9.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
9.4 Oncology
9.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.4.2 Market Share by Region, 2026 & 2036 (%)
9.5 Autoimmune Diseases
9.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.5.2 Market Share by Region, 2026 & 2036 (%)
9.6 Cardiovascular Diseases
9.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.6.2 Market Share by Region, 2026 & 2036 (%)
9.7 Metabolic Diseases
9.7.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.7.2 Market Share by Region, 2026 & 2036 (%)
9.8 Infectious Diseases
9.8.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.8.2 Market Share by Region, 2026 & 2036 (%)
9.9 Neurology
9.9.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.9.2 Market Share by Region, 2026 & 2036 (%)
9.10 Others
9.10.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
9.10.2 Market Share by Region, 2026 & 2036 (%)

10 Biopharmaceuticals Contract Manufacturing Market Analysis by Region
10.1 Key Findings
10.2 Regional Market Size Estimation and Forecast

11 North America Biopharmaceuticals Contract Manufacturing Market Analysis
11.1 Key Findings
11.2 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
11.3 North America Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
11.4 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
11.5 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
11.6 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
11.7 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
11.8 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
11.9 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
11.10 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
11.11 U.S. Biopharmaceuticals Contract Manufacturing Market Analysis
11.12 Canada Biopharmaceuticals Contract Manufacturing Market Analysis

12 Europe Biopharmaceuticals Contract Manufacturing Market Analysis
12.1 Key Findings
12.2 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
12.3 Europe Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
12.4 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
12.5 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
12.6 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
12.7 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
12.8 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
12.9 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
12.10 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
12.11 Germany Biopharmaceuticals Contract Manufacturing Market Analysis
12.12 UK Biopharmaceuticals Contract Manufacturing Market Analysis
12.13 France Biopharmaceuticals Contract Manufacturing Market Analysis
12.14 Italy Biopharmaceuticals Contract Manufacturing Market Analysis
12.15 Spain Biopharmaceuticals Contract Manufacturing Market Analysis
12.16 Russia Biopharmaceuticals Contract Manufacturing Market Analysis
12.17 Netherlands Biopharmaceuticals Contract Manufacturing Market Analysis
12.18 Switzerland Biopharmaceuticals Contract Manufacturing Market Analysis
12.19 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Analysis

13 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis
13.1 Key Findings
13.2 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
13.3 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
13.4 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
13.5 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
13.6 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
13.7 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
13.8 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
13.9 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
13.10 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
13.11 Japan Biopharmaceuticals Contract Manufacturing Market Analysis
13.12 China Biopharmaceuticals Contract Manufacturing Market Analysis
13.13 India Biopharmaceuticals Contract Manufacturing Market Analysis
13.14 Australia Biopharmaceuticals Contract Manufacturing Market Analysis
13.15 South Korea Biopharmaceuticals Contract Manufacturing Market Analysis
13.16 South-East Asia Biopharmaceuticals Contract Manufacturing Market Analysis
13.17 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis

14 Latin America Biopharmaceuticals Contract Manufacturing Market Analysis
14.1 Key Findings
14.2 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
14.3 Latin America Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
14.4 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
14.5 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
14.6 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
14.7 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
14.8 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
14.9 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
14.10 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
14.11 Brazil Biopharmaceuticals Contract Manufacturing Market Analysis
14.12 Mexico Biopharmaceuticals Contract Manufacturing Market Analysis
14.13 Argentina Biopharmaceuticals Contract Manufacturing Market Analysis
14.14 Colombia Biopharmaceuticals Contract Manufacturing Market Analysis
14.15 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Analysis

15 MEA Biopharmaceuticals Contract Manufacturing Market Analysis
15.1 Key Findings
15.2 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
15.3 MEA Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
15.4 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
15.5 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
15.6 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
15.7 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
15.8 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
15.9 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
15.10 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
15.11 GCC Biopharmaceuticals Contract Manufacturing Market Analysis
15.12 South Africa Biopharmaceuticals Contract Manufacturing Market Analysis
15.13 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Analysis

16 Company Profiles
16.1 AbbVie, Inc.
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Financial Analysis
16.1.3.1 Net Revenue, 2022-2025
16.1.3.2 R&D Expenses, 2022-2025
16.1.3.3 Regional Market Shares, 2025
16.1.3.4 Business Segment Market Shares, 2025
16.1.4 Service Benchmarking
16.2 AGC Biologics
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Service Benchmarking
16.2.4 Strategic Outlook
16.3 Avantor, Inc.
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Financial Analysis
16.3.3.1 Net Revenue, 2022-2025
16.3.3.2 Regional Market Shares, 2025
16.3.3.3 Business Segment Market Shares, 2025
16.3.4 Service Benchmarking
16.3.5 Strategic Outlook
16.4 Binex Co., Ltd.
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Service Benchmarking
16.5 Boehringer Ingelheim GmbH
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Financial Analysis
16.5.3.1 Net Revenue, 2022-2025
16.5.3.2 R&D Expenses, 2022-2025
16.5.3.3 Regional Market Shares, 2025
16.5.3.4 Business Segment Market Shares, 2025
16.5.4 Service Benchmarking
16.6 FUJIFILM Diosynth Biotechnologies
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Service Benchmarking
16.6.4 Strategic Outlook
16.7 Lonza
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Financial Analysis
16.7.3.1 Net Revenue, 2022-2025
16.7.3.2 R&D Expenses, 2022-2025
16.7.3.3 Regional Market Shares, 2025
16.7.3.4 Business Segment Market Shares, 2025
16.7.4 Service Benchmarking
16.7.5 Strategic Outlook
16.8 ProBioGen
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Service Benchmarking
16.8.4 Strategic Outlook
16.9 Rentschler Biopharma SE
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Service Benchmarking
16.9.4 Strategic Outlook
16.10 Samsung Biologics
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Service Benchmarking
16.10.4 Strategic Outlook
16.11 Sandoz
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Financial Analysis
16.11.3.1 Net Revenue, 2022-2025
16.11.3.2 R&D Expenses, 2022-2025
16.11.3.3 Regional Market Shares, 2025
16.11.3.4 Business Segment Market Shares, 2025
16.11.4 Service Benchmarking
16.11.5 Strategic Outlook
16.12 TOYOBO CO., LTD.
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Service Benchmarking
16.13 WuXi Biologics
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Financial Analysis
16.13.3.1 Net Revenue, 2022-2025
16.13.3.2 Regional Market Shares, 2025
16.13.3.3 Business Segment Market Shares, 2025
16.13.4 Service Benchmarking
16.13.5 Strategic Outlook
16.14 JRS PHARMA
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Service Benchmarking
16.15 Thermo Fisher Scientific
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Financial Analysis
16.15.3.1 Net Revenue, 2022-2025
16.15.3.2 R&D, 2022-2025
16.15.3.3 Regional Market Shares, 2025
16.15.3.4 Business Segment Market Shares, 2025
16.15.4 Service Benchmarking
16.16 Cambrex Corporation
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Service Benchmarking
16.16.4 Strategic Outlook
16.17 Curia Global, Inc.
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Service Benchmarking
16.17.4 Strategic Outlook
16.18 Pfizer CentreOne
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Financial Analysis
16.18.3.1 Net Revenue, 2022-2025
16.18.3.2 R&D, 2022-2025
16.18.3.3 Regional Market Shares, 2025
16.18.3.4 Business Segment Market Shares, 2025
16.18.4 Service Benchmarking
16.19 Jubilant Pharma Limited
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Service Benchmarking
16.20 Catalent, Inc. (Novo Holdings)
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Financial Analysis
16.20.3.1 Net Revenue, 2022-2025
16.20.4 Service Benchmarking
16.20.5 Strategic Outlook
16.21 KBI Biopharma
16.21.1 Company Snapshot
16.21.2 Company Overview
16.21.3 Service Benchmarking
16.21.4 Strategic Outlook
16.22 Cytiva
16.22.1 Company Snapshot
16.22.2 Company Overview
16.22.3 Service Benchmarking
16.22.4 Strategic Outlook

17 Conclusion and Recommendations
17.1 Concluding Remarks from Visiongain
17.2 Recommendations for Market Players
List of Other Notable Players
List of Associations Mentioned in the Report
Associated Visiongain Reports

 

ページTOPに戻る



List of Tables/Graphs

List of Tables
Table 1 Biopharmaceuticals Contract Manufacturing Market Snapshot, 2026 & 2036 (US$ million, CAGR %)
Table 2 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): “V” Shaped Recovery
Table 3 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): “U” Shaped Recovery
Table 4 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): “L” Shaped Recovery
Table 5 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 6 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 7 Non-mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 8 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 9 Process Development Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 10 Fill & Finish Operations Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 11 Analytical & QC Studies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 12 Packaging Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 13 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 14 Biologics Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 15 Biosimilars Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 16 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 17 Small Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 18 Mid-sized Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 19 Large Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 20 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 21 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 22 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 23 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 24 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 25 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 26 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 27 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 28 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 29 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 30 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 31 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 32 U.S. Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 33 Canada Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 34 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 35 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 36 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 37 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 38 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 39 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 40 Germany Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 41 UK Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 42 France Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 43 Italy Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 44 Spain Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 45 Russia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 46 Netherlands Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 47 Switzerland Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 48 Rest of Europe Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 49 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 50 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 51 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 52 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 53 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 54 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 55 Japan Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 56 China Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 57 India Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 58 Australia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 59 South Korea Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 60 South-East Asia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 61 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 62 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 63 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 64 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 65 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 66 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 67 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 68 Brazil Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 69 Mexico Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 70 Argentina Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 71 Colombia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 72 Rest of Latin America Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 73 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 74 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 75 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 76 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 77 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 78 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
Table 79 GCC Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 80 South Africa Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 81 Rest of MEA Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
Table 82 AbbVie, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 AbbVie, Inc.: Service Benchmarking
Table 84 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 AGC Biologics: Service Benchmarking
Table 86 AGC Biologics: Strategic Outlook
Table 87 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Avantor, Inc.: Service Benchmarking
Table 89 Avantor, Inc.: Strategic Outlook
Table 90 Binex Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Binex Co., Ltd.: Service Benchmarking
Table 92 Boehringer Ingelheim GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Boehringer Ingelheim GmbH: Service Benchmarking
Table 94 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
Table 96 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
Table 97 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Lonza: Service Benchmarking
Table 99 Lonza: Strategic Outlook
Table 100 ProBioGen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 ProBioGen: Service Benchmarking
Table 102 ProBioGen: Strategic Outlook
Table 103 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Rentschler Biopharma SE: Service Benchmarking
Table 105 Rentschler Biopharma SE: Strategic Outlook
Table 106 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Samsung Biologics: Service Benchmarking
Table 108 Samsung Biologics: Strategic Outlook
Table 109 Sandoz: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Sandoz: Service Benchmarking
Table 111 Sandoz: Strategic Outlook
Table 112 TOYOBO CO., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 TOYOBO CO., LTD.: Service Benchmarking
Table 114 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 WuXi Biologics: Service Benchmarking
Table 116 WuXi Biologics: Strategic Outlook
Table 117 JRS PHARMA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 JRS PHARMA: Service Benchmarking
Table 119 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Thermo Fisher Scientific: Service Benchmarking
Table 121 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Cambrex Corporation: Service Benchmarking
Table 123 Cambrex Corporation: Strategic Outlook
Table 124 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Curia Global, Inc.: Service Benchmarking
Table 126 Curia Global, Inc.: Strategic Outlook
Table 127 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Pfizer CentreOne: Service Benchmarking
Table 129 Jubilant Pharma Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Jubilant Pharma Limited: Service Benchmarking
Table 131 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 132 Catalent, Inc: Service Benchmarking
Table 133 Catalent, Inc: Strategic Outlook
Table 134 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 135 KBI Biopharma: Service Benchmarking
Table 136 KBI Biopharma: Strategic Outlook
Table 137 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 138 Cytiva: Service Benchmarking
Table 139 Cytiva: Strategic Outlook

List of Figures
Figure 1 Biopharmaceuticals Contract Manufacturing Market Segmentation
Figure 2 Biopharmaceuticals Contract Manufacturing Market by Source: Market Attractiveness Index
Figure 3 Biopharmaceuticals Contract Manufacturing Market by Service: Market Attractiveness Index
Figure 4 Biopharmaceuticals Contract Manufacturing Market by Product: Market Attractiveness Index
Figure 5 Biopharmaceuticals Contract Manufacturing Market by Company Size: Market Attractiveness Index
Figure 6 Biopharmaceuticals Contract Manufacturing Market by Scale of Operations: Market Attractiveness Index
Figure 7 Biopharmaceuticals Contract Manufacturing Market by Therapeutic Area: Market Attractiveness Index
Figure 8 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Region
Figure 9 Biopharmaceuticals Contract Manufacturing Market: Market Dynamics
Figure 10 Biopharmaceuticals Contract Manufacturing Market: Impact Analysis
Figure 11 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 12 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 13 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 14 Short Term & Long Term Planning
Figure 15 Impact of U.S. and China Trade War
Figure 1 Most Impacted Countries
Figure 2 SWOT Analysis
Figure 3 Porter’s Five Forces Analysis
Figure 4 PEST Analysis
Figure 5 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
Figure 6 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 7 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026, 2031 & 2036 (%)
Figure 8 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 9 Mammalian Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 10 Non-mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 11 Non-mammalian Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 12 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
Figure 13 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 14 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026, 2031 & 2036 (%)
Figure 15 Process Development Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 16 Process Development Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 17 Fill & Finish Operations Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 18 Fill & Finish Operations Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 19 Analytical & QC Studies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 20 Analytical & QC Studies Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 21 Packaging Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 22 Packaging Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 23 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Product
Figure 24 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 25 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026, 2031 & 2036 (%)
Figure 26 Biologics Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 27 Biologics Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 28 Biosimilars Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 29 Biosimilars Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 30 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Company Size
Figure 31 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 32 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026, 2031 & 2036 (%)
Figure 33 Small Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 34 Small Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Mid-sized Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 36 Mid-sized Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Large Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 38 Large Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 39 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Scale of Operations
Figure 40 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 41 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026, 2031 & 2036 (%)
Figure 42 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 43 Preclinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 44 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 45 Clinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 46 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 47 Commercial Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Therapeutic Area
Figure 49 Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 50 Biopharmaceuticals Contract Manufacturing Market Share Forecast Therapeutic Area, 2026, 2031 & 2036 (%)
Figure 51 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 52 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 53 Autoimmune Diseses Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 54 Autoimmune Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 55 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 56 Cardiovascular Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 57 Metabolic Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 58 Metabolic Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 60 Infectious Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Neurology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 62 Neurology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 63 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
Figure 64 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 65 Biopharmaceuticals Contract Manufacturing Market Forecast by Region 2026, 2031 & 2036 (Revenue, CAGR%)
Figure 66 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Region 2026, 2031 & 2036 (%)
Figure 67 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Mn)
Figure 68 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 69 North America Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 70 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 71 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 72 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 73 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 74 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 75 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 76 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 77 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 78 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 79 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 80 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 81 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 82 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 83 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 84 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 85 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 86 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 87 Europe Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 88 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 89 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 90 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 91 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 92 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 93 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 94 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 95 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 96 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 97 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 98 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 99 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 100 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 101 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 102 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 103 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 104 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 105 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 106 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 107 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 108 Netherlands Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 109 Switzerland Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 110 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 111 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 112 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 113 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 114 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 115 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 116 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 117 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 118 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 119 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 120 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 121 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 122 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 123 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 124 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 125 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 126 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 127 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 128 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 129 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 130 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 131 South Korea Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 132 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 133 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 134 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 135 Latin America Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 136 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 137 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 138 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 139 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 140 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 141 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 142 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 143 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 144 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 145 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 146 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 147 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 148 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 149 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 150 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 151 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 152 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 153 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 154 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 155 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
Figure 156 MEA Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
Figure 157 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
Figure 158 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
Figure 159 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
Figure 160 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
Figure 161 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
Figure 162 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
Figure 163 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
Figure 164 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
Figure 165 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
Figure 166 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
Figure 167 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
Figure 168 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
Figure 169 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
Figure 170 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 171 GCC Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 172 South Africa Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 173 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
Figure 174 AbbVie, Inc.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 175 AbbVie, Inc.: R&D Expenses, 2022-2025 (US$ Million, AGR %)
Figure 176 AbbVie, Inc.: Regional Market Shares, 2025 (%)
Figure 177 AbbVie, Inc.: Business Segment Market Shares, 2025 (%)
Figure 178 Avantor, Inc.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 179 Avantor, Inc.: Regional Market Shares, 2025 (%)
Figure 180 Avantor, Inc.: Business Segment Market Share, 2025 (%)
Figure 181 Boehringer Ingelheim GmbH: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 182 Boehringer Ingelheim GmbH: R&D Expenses, 2022-2025 (US$ Million, AGR %)
Figure 183 Boehringer Ingelheim GmbH: Regional Market Shares, 2025 (%)
Figure 184 Boehringer Ingelheim GmbH.: Business Segment Market Share, 2025 (%)
Figure 185 Lonza: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 186 Lonza: R&D Expenses, 2022-2025 (US$ Million, AGR %)
Figure 187 Lonza: Regional Market Shares, 2025 (%)
Figure 188 Lonza: Business Segment Market Share, 2025 (%)
Figure 189 Sandoz: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 190 Sandoz: R&D Expenses, 2022-2025 (US$ Million, AGR %)
Figure 191 Sandoz: Regional Market Share (%), 2025
Figure 192 Sandoz: Business Segment Market Share, 2025 (%)
Figure 193 WuXi Biologics: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 194 WuXi Biologics: Regional Market Shares, 2025 (%)
Figure 195 WuXi Biologics: Business Segment Market Shares, 2025 (%)
Figure 196 Thermo Fisher Scientific: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 197 Thermo Fisher Scientific: R&D, 2022-2025 (US$ Million, AGR %)
Figure 198 Thermo Fisher Scientific: Regional Market Shares, 2025 (%)
Figure 199 Thermo Fisher Scientific: Business Segment Market Shares, 2025 (%)
Figure 200 Pfizer CentreOne: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 201 Pfizer CentreOne: R&D, 2022-2025 (US$ Million, AGR %)
Figure 202 Pfizer CentreOne: Regional Market Shares, 2025 (%)
Figure 203 Pfizer CentreOne: Business Segment Market Shares, 2025 (%)
Figure 204 Catalent, Inc: Net Revenue, 2022-2025 (US$ Million, AGR %)

 

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオ薬物）の最新刊レポート

Visiongain社の ヘルスケアと医薬・化学品分野 での最新刊レポート

本レポートと同じKEY WORD（biopharmaceuticals）の最新刊レポート



関連レポート（キーワード「バイオ医薬品」）


よくあるご質問


Visiongain社はどのような調査会社ですか?


英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

当社ご利用のメリット
  1. ① お探しの情報に合わせてレポートをご紹介
  2. ② レポートで不足している情報はカスタマイズで対応可能
  3. ③ 特許情報、海外の法規制の取り組みなどディープな調査も対応可能
  4. ④ 円貨で請求書払い＆万全のアフターフォロー

 

2026/10/27　10:25

158.64 円

177.60 円

214.31 円

ページTOPに戻る

株式会社 データリソース　Data Resource, Inc.
東京都千代田区丸の内3-3-1 新東京ビル4F 430


A member of CORSS Business Producers Inc.
データリソースは2025年5月より
CROSS Business Producers株式会社 の100%子会社になりました。

電話：03-3582-2531
FAX：03-6551-2556
Eメール：office@dri.co.jp

会社概要 FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2025　DATA RESOURCE, Inc. ALL RIGHTS RESERVED.